111 related articles for article (PubMed ID: 18538948)
61. Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas.
Burrell JS; Walker-Samuel S; Baker LC; Boult JK; Jamin Y; Ryan AJ; Waterton JC; Halliday J; Robinson SP
Int J Cancer; 2012 Oct; 131(8):1854-62. PubMed ID: 22290271
[TBL] [Abstract][Full Text] [Related]
62. Nanoparticle Contrast-enhanced T1-Mapping Enables Estimation of Placental Fractional Blood Volume in a Pregnant Mouse Model.
Badachhape AA; Devkota L; Stupin IV; Sarkar P; Srivastava M; Tanifum EA; Fox KA; Yallampalli C; Annapragada AV; Ghaghada KB
Sci Rep; 2019 Dec; 9(1):18707. PubMed ID: 31822711
[TBL] [Abstract][Full Text] [Related]
63. Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors.
Wade TP; Kozlowski P
Neoplasia; 2007 Jul; 9(7):563-8. PubMed ID: 17710159
[TBL] [Abstract][Full Text] [Related]
64. Assessment of vessel size by MRI in an orthotopic model of human pancreatic cancer.
Flexman JA; Yung A; Yapp DT; Ng SS; Kozlowski P
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():851-4. PubMed ID: 19162790
[TBL] [Abstract][Full Text] [Related]
65. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis.
Ungersma SE; Pacheco G; Ho C; Yee SF; Ross J; van Bruggen N; Peale FV; Ross S; Carano RA
Magn Reson Med; 2010 Jun; 63(6):1637-47. PubMed ID: 20512867
[TBL] [Abstract][Full Text] [Related]
66. Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging.
Seshadri M; Sacadura NT; Coulthard T
Angiogenesis; 2011 Dec; 14(4):491-501. PubMed ID: 21901534
[TBL] [Abstract][Full Text] [Related]
67. Antivascular therapy of cancer: DMXAA.
Baguley BC
Lancet Oncol; 2003 Mar; 4(3):141-8. PubMed ID: 12623359
[TBL] [Abstract][Full Text] [Related]
68. Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging.
Gore JC; Majumdar S
Magn Reson Med; 1990 May; 14(2):242-8. PubMed ID: 2189053
[TBL] [Abstract][Full Text] [Related]
69. Vascular priming enhances chemotherapeutic efficacy against head and neck cancer.
Folaron M; Kalmuk J; Lockwood J; Frangou C; Vokes J; Turowski SG; Merzianu M; Rigual NR; Sullivan-Nasca M; Kuriakose MA; Hicks WL; Singh AK; Seshadri M
Oral Oncol; 2013 Sep; 49(9):893-902. PubMed ID: 23890930
[TBL] [Abstract][Full Text] [Related]
70. Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course.
Schwarz AJ; Reese T; Gozzi A; Bifone A
Magn Reson Imaging; 2003 Dec; 21(10):1191-200. PubMed ID: 14725926
[TBL] [Abstract][Full Text] [Related]
71. Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.
Robinson SP; Kalber TL; Howe FA; McIntyre DJ; Griffiths JR; Blakey DC; Whittaker L; Ryan AJ; Waterton JC
Neoplasia; 2005 May; 7(5):466-74. PubMed ID: 15967099
[TBL] [Abstract][Full Text] [Related]
72. Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas.
Moding EJ; Clark DP; Qi Y; Li Y; Ma Y; Ghaghada K; Johnson GA; Kirsch DG; Badea CT
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1353-9. PubMed ID: 23122984
[TBL] [Abstract][Full Text] [Related]
73. Erratum to: Ungersma SE, Pacheco G, Ho C, Yee SF, Ross J, van Bruggen N, Peale FV Jr, Ross S, Carano RA. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med 2010;63:1637–1647.
Ungersma SE; Pacheco G; Ho C; Yee SF; Ross J; van Bruggen N; Peale FV; Ross S; Carano RA
Magn Reson Med; 2011 Mar; 65(3):889-99. PubMed ID: 21442797
[TBL] [Abstract][Full Text] [Related]
74. Acute vascular disruption by 5,6-dimethylxanthenone-4-acetic Acid in an orthotopic model of human head and neck cancer.
Seshadri M; Toth K
Transl Oncol; 2009 Aug; 2(3):121-7. PubMed ID: 19701496
[TBL] [Abstract][Full Text] [Related]
75. Noninvasive Assessment of Losartan-Induced Increase in Functional Microvasculature and Drug Delivery in Pancreatic Ductal Adenocarcinoma.
Kumar V; Boucher Y; Liu H; Ferreira D; Hooker J; Catana C; Hoover AJ; Ritter T; Jain RK; Guimaraes AR
Transl Oncol; 2016 Oct; 9(5):431-437. PubMed ID: 27751347
[TBL] [Abstract][Full Text] [Related]
76. The Characteristics of Vascular Growth in VX2 Tumor Measured by MRI and Micro-CT.
Qi XL; Liu J; Burns PN; Wright GA
J Oncol; 2012; 2012():362096. PubMed ID: 21941548
[TBL] [Abstract][Full Text] [Related]
77. The measurement and visualisation of vessel blood flow by magnetic resonance imaging.
Smith MA
Clin Phys Physiol Meas; 1990 May; 11(2):101-23. PubMed ID: 2194733
[No Abstract] [Full Text] [Related]
78. Reply to letter by Dyverfeldt and Ebbers regarding the article "Estimation of turbulent kinetic energy using 4D phase-contrast MRI: Effect of scan parameters and target vessel size".
Ha H; Hwang D; Kim GB; Kweon J; Lee SJ; Baek J; Kim YH; Kim N; Yang DH
Magn Reson Imaging; 2016 Nov; 34(9):1338-1340. PubMed ID: 27498248
[No Abstract] [Full Text] [Related]
79. Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review.
Oronsky BT; Scicinski JJ; Reid T; Knox S
Transl Oncol; 2012 Jun; 5(3):133-40. PubMed ID: 22741032
[TBL] [Abstract][Full Text] [Related]
80. Differentiation of Cerebral Neoplasms with Vessel Size Imaging (VSI).
Foda A; Kellner E; Gunawardana A; Gao X; Janz M; Kufner A; Khalil AA; Geran R; Mekle R; Fiebach JB; Galinovic I
Clin Neuroradiol; 2022 Mar; 32(1):239-248. PubMed ID: 34940899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
